MYGN
Myriad Genetics (MYGN)
NASDAQ
$5.68+$0.10 (+1.89%)
Price as of Oct 22, 2026 7:55 PM EDT
  • $532.8M
    Market Cap
  • -29.13%
    1-Year Change
  • Diagnostics & Research
    Industry

Earnings Score

Score: 75
Valuation
MYGN
vs History
vs S&P 500
Profitability
0
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 35
Valuation
MYGN
vs History
vs S&P 500
3-Month Momentum
-31.98%
12-Month Momentum
-50.12%
3-Month Risk Adjusted Momentum
-59.27%
12-Month Risk Adjusted Momentum
-64.82%

True Yield

N/A
Valuation
MYGN
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.24%
Net Debt Paydown Yield
-0.07%

Financial Health Score

Score: 41
Valuation
MYGN
vs History
vs S&P 500
Ohlson's O-Score
6